AltMountain

HHLR Advisors, LTD.

Singapore, Singapore · CRD 166112
Hedge fund managerExempt reporting

HHLR Advisors, LTD. is an exempt reporting adviser based in Singapore, Singapore that reports managing 2 hedge funds on Form ADV. Its private funds, of all types, hold $22.1 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated -16.7% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +10.4% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.

Regulatory assets under management
—Form ADV Item 5.F
Gross assets of private funds
$22.1 billionAll private fund types, Form ADV
Hedge funds managed
22 private funds in total
Employees
—Form ADV Item 5.A
Registration
Exempt reporting adviserCRD 166112
Latest Form ADV
03/31/2026Disciplinary disclosures: none reported

Estimated 13F portfolio performance

Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.

Estimated from 13F · 2026 YTD-16.7%Through Q2 2026 · S&P 500 +9.5%
Estimated from 13F · 2 years+10.4%Q3 2024 – Q2 2026
S&P 500+37.2%Same quarters, price only
13F holdings$832.1 million35 positions, 2026-06-30
$100$129$159Q3 2024Q1 2025Q3 2025Q1 202613F est. $110S&P 500 $137
QuarterEst. 13F returnS&P 500
Q2 2026-5.9%+14.8%
Q1 2026-11.5%-4.6%
Q4 2025-16.4%+2.4%
Q3 2025+23.8%+7.8%
Q2 2025-0.9%+10.4%
Q1 2025+25.3%-4.5%
Q4 2024-16.6%+2.1%
Q3 2024+23.6%+5.4%

Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures

Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.

13F holdings as of Sep 30, 2026

All 40 share positions ($1,543,219,087) reported by HHLR Advisors, LTD. on Form 13F for the quarter ended Sep 30, 2026, filed Nov 16, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.

Share of the reported 13F portfolio, ten largest positions

  • PDD Holdings Inc22.46%
  • Alibaba Group Hldg LTD17.35%
  • Legend Biotech Corp10.78%
  • Full Truck Alliance Co LTD10.50%
  • Arrivent Biopharma Inc7.71%
  • Vipshop Hldgs LTD5.56%
  • Trip Com Group LTD5.39%
  • Futu Hldgs LTD4.52%
  • Marvell Technology Inc2.64%
  • Cytek Biosciences Inc2.57%
StockValue% of 13F portfolioSharesShares vs prior quarter
PDD Holdings Inc$346,599,18022.46%4,447,000+789.40%
Alibaba Group Hldg LTD$267,753,09217.35%2,489,800+1,253.64%
Legend Biotech Corp$166,308,76310.78%8,361,426+39.72%
Full Truck Alliance Co LTD$162,065,96610.50%19,596,852New
Arrivent Biopharma Inc$118,973,6637.71%3,929,117Unchanged
Vipshop Hldgs LTD$85,726,0265.56%6,852,600+97.46%
Trip Com Group LTD$83,177,4305.39%2,127,300New
Futu Hldgs LTD$69,757,0504.52%631,000-64.32%
Marvell Technology Inc$40,670,6382.64%153,933-5.52%
Cytek Biosciences Inc$39,675,8992.57%6,657,030Unchanged
Alamar Biosciences Inc$32,586,6602.11%956,462Unchanged
Odyssey Therapeutics Inc$18,479,3961.20%831,656Unchanged
Yatsen Hldg LTD$13,582,7270.88%4,885,873Unchanged
Maze Therapeutics Inc$9,948,6950.64%366,030Unchanged
Contineum Therapeutics Inc$8,982,5030.58%669,337Unchanged
Agora Inc$8,771,9520.57%2,098,553Unchanged
Taiwan Semiconductor Manufac$8,625,1840.56%18,907+21.90%
Novabridge Biosciences$8,163,4750.53%5,980,568Unchanged
Cerebras Systems Inc$7,637,8840.49%42,994New
Amazon Com Inc$6,028,9320.39%24,198New
Ke Hldgs Inc$4,542,9620.29%269,612-87.85%
Netease Com Inc$4,240,4790.27%34,999Unchanged
Intel Corp$4,170,5380.27%34,688+142.57%
Nvidia Corporation$3,209,6530.21%14,054Unchanged
Ge Aerospace$3,136,3280.20%10,043Unchanged
Tuya Inc$2,659,4800.17%1,564,400Unchanged
Pacific Biosciences Calif In$2,177,7740.14%918,892Unchanged
Alphabet Inc$1,996,3520.13%5,802New
Microsoft Corp$1,866,9560.12%3,640New
Lumentum Hldgs Inc$1,699,7050.11%1,750-46.97%
Paypay Corp$1,635,5480.11%104,175New
Mogu Inc$1,576,3690.10%847,510Unchanged
SK Hynix Inc Fsponsored ADR 1 ADR Reps 0.1 ORD SHS$1,478,3560.10%8,028New
S&P Global Inc$1,227,5910.08%3,112New
Moodys Corp$1,207,5320.08%2,659New
Equinox Gold Corp$894,3550.06%80,500Unchanged
Zoom Communications Inc$817,8380.05%9,010Unchanged
Gossamer Bio Inc$736,7740.05%62,175New
Aligos Therapeutics Inc$429,2710.03%76,247Unchanged
Ridgetech Inc$1110.00%135-0.74%

Changes since Jun 30, 2026

Comparing the share counts in the two quarter-end filings: 11 new positions, 6 sold out, 6 increased, 5 reduced and 18 unchanged.

Number of positions (a count, not dollars)

  • New positions11
  • Increased6
  • Unchanged18
  • Reduced5
  • Sold out6

New positions

StockValueShares
Full Truck Alliance Co LTD$162,065,96619,596,852
Trip Com Group LTD$83,177,4302,127,300
Cerebras Systems Inc$7,637,88442,994
Amazon Com Inc$6,028,93224,198
Alphabet Inc$1,996,3525,802
Microsoft Corp$1,866,9563,640
Paypay Corp$1,635,548104,175
SK Hynix Inc Fsponsored ADR 1 ADR Reps 0.1 ORD SHS$1,478,3568,028
S&P Global Inc$1,227,5913,112
Moodys Corp$1,207,5322,659
Gossamer Bio Inc$736,77462,175

Sold out

StockValue at Jun 30, 2026Shares held then
Sagimet Biosciences Inc$5,602,704724,800
Corning Inc$2,622,24410,266
Coherent Corp$2,531,3146,417
Webull Corp$2,020,268309,857
Texas Instrs Inc$1,430,7364,800
Gossamer Bio Inc$818,7274,974,041

Largest increases

StockChange in sharesChangeValue nowShares now
PDD Holdings Inc+3,947,000+789.40%$346,599,1804,447,000
Alibaba Group Hldg LTD+2,305,866+1,253.64%$267,753,0922,489,800
Legend Biotech Corp+2,376,876+39.72%$166,308,7638,361,426
Vipshop Hldgs LTD+3,382,200+97.46%$85,726,0266,852,600
Intel Corp+20,388+142.57%$4,170,53834,688
Taiwan Semiconductor Manufac+3,397+21.90%$8,625,18418,907

Largest reductions

StockChange in sharesChangeValue nowShares now
Futu Hldgs LTD-1,137,283-64.32%$69,757,050631,000
Ke Hldgs Inc-1,948,765-87.85%$4,542,962269,612
Marvell Technology Inc-9,000-5.52%$40,670,638153,933
Lumentum Hldgs Inc-1,550-46.97%$1,699,7051,750
Ridgetech Inc-1-0.74%$111135

Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.

From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures

Large ownership stakes (Schedule 13D and 13G)

CompanyFilingPercent of classSharesFiledSource
NovaBridge Biosciences13D amendment4.9%13,295,306Nov 5, 2026SEC.gov ↗

A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Nov 5, 2026, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Source: U.S. Securities and Exchange Commission, EDGAR.

Private funds reported on Form ADV (4)

As reported in the adviser's Form ADV filed Mar 29, 2024. Funds also listed from Form D are shown above.

From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌​‌⁠